At the news
? NEUTRALIMPACT 2/10 CLUSTER filed Jun 15, 2026 at 17:55 ET
Five BeOne Medicines insiders, including the CEO, sold a total of $1.98M in open-market shares over a one-week window. The selling is trivial relative to the $29.4B market cap (0.007%), and the cluster is accompanied by large equity grants to the same executives, suggesting routine compensation-related liquidity rather than a bearish signal.
- CEO John Oyler sold $1.03M worth of shares on 2026-06-08.
- Total open-market sales by 5 insiders: $1.98M.
- Total sales represent ~0.007% of ONC's $29.4B market cap.
- Multiple executives received large equity grants (non-cash) on the same date as some sales.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access